Search Icon

Covid-19 vaccine - Equitable vaccine distribution and vaccine hesitancy

Avatar: Ruth Nigussie
Ruth Nigussie, Sara MogesAugust 10, 2021
City: Addis AbabaReports
Covid-19 vaccine - Equitable vaccine distribution and vaccine hesitancy

Covid-19 was first reported as spreading in Wuhan, China, in December 2019.  As of July 9, 2021, it has infected 185,291,530 million people and killed 4,010,834. The US, India, and Brazil have borne the highest number of deaths, in some instances recording more than  4,000 deaths per day. The after-effects of the pandemic are still being felt and stretch beyond health issues. 

The pandemic has impacted economies, impeded social interaction, and impacted the political sphere as restless citizens have protested. In every part of the world governments, communities and individuals have tried to plot a path out of the crisis. Finding a vaccine quickly was therefore essential. 

On March 16, 2020, the first Covid-19 vaccine candidate entered a human clinical trial. The news of a viable vaccine gave hope to the world. However, the successful development process has not carried through into vaccine production and rollout to billions around the world. The world is currently facing multifaceted challenges in this regard. The main challenge is an equitable distribution of the vaccine around the globe. The second is vaccine hesitancy, a reality that exists for so many different reasons among the general population.

This report will aim to show the truth and myths about Covid-19 vaccines concerning vaccine development, hesitancy, and distribution. Read the whole story here.

Author: undefined undefined
A PIECE BYRuth Nigussie

Author: undefined undefined
A PIECE BYSara Moges